Morpholino

MO2-ucmab

ID

ZDB-MRPHLNO-111110-2

Name

MO2-ucmab

Previous Names

None

Target

Sequence

5' - ATTTAGCGGAGCAGGAGTGAAGAAA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO. Targets the 5'UTR.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-ucmab

No data available

Phenotype

Phenotype resulting from MO2-ucmab

Phenotype	Fish	Figures
bone mineralization disrupted, abnormal	KOLN + MO2-ucmab	Fig. 6 from Neacsu et al., 2011
embryo development disrupted, abnormal	KOLN + MO2-ucmab	Fig. 5 from Neacsu et al., 2011
head decreased size, abnormal	KOLN + MO2-ucmab	Fig. 5 from Neacsu et al., 2011
head malformed, abnormal	KOLN + MO2-ucmab	Fig. 5 from Neacsu et al., 2011
notochord malformed, abnormal	KOLN + MO2-ucmab	Fig. 5 from Neacsu et al., 2011
whole organism decreased length, abnormal	KOLN + MO2-ucmab	Fig. 5 from Neacsu et al., 2011
whole organism lacks parts or has fewer parts of type pharyngeal arch 3-7, abnormal	KOLN + MO2-ucmab	Fig. 5 from Neacsu et al., 2011
whole organism lacks parts or has fewer parts of type cartilage element, abnormal	KOLN + MO2-ucmab	Fig. 5 from Neacsu et al., 2011

Phenotype of all Fish created by or utilizing MO2-ucmab

Phenotype	Fish	Conditions	Figures
notochord malformed, abnormal	KOLN + MO2-ucmab	standard conditions	Fig. 5 from Neacsu et al., 2011
head decreased size, abnormal	KOLN + MO2-ucmab	standard conditions	Fig. 5 from Neacsu et al., 2011
whole organism lacks parts or has fewer parts of type cartilage element, abnormal	KOLN + MO2-ucmab	standard conditions	Fig. 5 from Neacsu et al., 2011
embryo development disrupted, abnormal	KOLN + MO2-ucmab	standard conditions	Fig. 5 from Neacsu et al., 2011
whole organism lacks parts or has fewer parts of type pharyngeal arch 3-7, abnormal	KOLN + MO2-ucmab	standard conditions	Fig. 5 from Neacsu et al., 2011
whole organism decreased length, abnormal	KOLN + MO2-ucmab	standard conditions	Fig. 5 from Neacsu et al., 2011
head malformed, abnormal	KOLN + MO2-ucmab	standard conditions	Fig. 5 from Neacsu et al., 2011
bone mineralization disrupted, abnormal	KOLN + MO2-ucmab	standard conditions	Fig. 6 from Neacsu et al., 2011

Citations